药理和营养调节的新陈代谢和新陈代谢在心脏代谢疾病
Anna Maria Witkowska1, Joe-Elie Salem2
1Department of Food Biotechnology, Faculty of Health Sciences, Medical University of Bialystok, Szpitalna 37, 15-295 Białystok, Poland.
Biomolecules
|September 28, 2023
概括
肠道微生物群影响宿主新陈代谢和心脏代谢健康. 结合代谢学和基因组学方法,揭示了饮食,药物和营养素如何影响这些疾病,确定了未来的治疗点.
科学领域:
- 微生物学与新陈代谢
- 肠道微生物组研究研究
- 心脏代谢疾病病因 病因学
背景情况:
- 心脏代谢障碍对全球健康构成重大负担.
- 肠道微生物群在宿主新陈代谢中起着至关重要的作用.
- 了解宿主微生物群相互作用是管理心脏代谢健康的关键.
研究的目的:
- 审查整合代谢和代谢基因组方法的研究.
- 通过肠道微生物群阐明干预措施对心脏代谢健康的影响.
- 为了确定心脏代谢疾病的新型治疗点.
主要方法:
- 对结合代谢学和转基因组学研究的文献综述.
- 对药物,饮食,营养素和食物影响的数据分析.
- 专注于宿主-便微生物群的代谢相互作用.
主要成果:
- 代谢和代谢基因组数据揭示了肠道微生物群和宿主代谢之间的复杂相互作用.
- 特定的饮食成分,营养素和药物调节肠道微生物群的组成和功能.
- 这些调节对心脏代谢健康结果有重大影响.
结论:
- 组合的奥米克方法是了解心脏代谢疾病的强大工具.
- 准肠道微生物群为预防和治疗心脏代谢疾病提供了有希望的途径.
- 需要进一步的研究来将这些发现转化为临床应用.
相关概念视频
Regulation of Metabolism
9.5K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.5K
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Factors Affecting Drug Biotransformation: Biological
172
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
172
Overview of Carbohydrate Metabolism
1.1K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.1K
Pathophysiology of Cardiac Performance
694
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
694
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11


